| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
BTIG analyst Ryan Zimmerman upgrades AVITA Medical (NASDAQ:RCEL) from Sell to Neutral.
Lake Street analyst Frank Takkinen downgrades AVITA Medical (NASDAQ:RCEL) from Buy to Hold and lowers the price target from ...